Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational study.
Jin-Mo ParkDonghwi ParkHyung-Jun KimJin-Sung ParkPublished in: BMC neurology (2022)
This study verifies previous reported outcomes of edaravone in 16 Korean ALS patients, indicating a modest effect with a favorable safety profile.